KRAS and pancreatic neoplasm: It is well-established that the PI3K/Akt pathway is activated in human PDAC as well as K-Ras-driven mouse models of pancreatic cancer (Jimeno et al., 2008; Kennedy et al., 2011; Eser et al., 2013).